ICCM

Icecure Medical Ltd

2.20

Sep 03 • 3:59 PM ET -0.06 (-2.65%)

2.22

Aftermarket • 6:41 PM ET +0.02 (0.91%)

Healthcare Medical Devices Israel Nano NASD

Peers: ADGM IRIX MODD NMTC CTSO NSPR ELUT NSYS TELA MOBI

Scroll to Statements

Index	-
Market Cap	7.53M
Enterprise Value	-4.41M
Income	-16.88M
Sales	3.95M
Book/sh	3.47
Cash/sh	3.51
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	69
IPO	Nov 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	1.91
P/B	0.63
P/C	0.63
P/FCF	-
EV/EBITDA	-
EV/Sales	-1.12
Quick Ratio	2.44
Current Ratio	2.87
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-6.57
EPS next Y	-3.66
EPS next Q	-1.16
EPS this Y	25.69%
EPS next Y	31.59%
EPS next 5Y	32.04%
EPS past 3/5Y	19.27% 32.65%
Sales past 3/5Y	3.08% -2.67%
EPS Y/Y TTM	20.47%
Sales Y/Y TTM	41.62%
EPS Q/Q	22.14%
Sales Q/Q	72.76%
Earnings	Aug 12 BMO
EPS/Sales Surpr.	-1.87% -37.46%

Insider Own	67.88%
Insider Trans	0.00%
Inst Own	12.60%
Inst Trans	7.35%
ROA	-119.31%
ROE	-228.31%
ROIC	-141.65%
Gross Margin	36.10%
Oper. Margin	-423.69%
Profit Margin	-427.67%
SMA20	-15.81%
SMA50	-34.26%
SMA200	-81.17%
Trades

Shs Outstand	3.43M
Shs Float	1.10M
Short Float	3.71%
Short Ratio	0.01
Short Interest	0.04M
52W High	42.00 -94.76%
52W Low	2.12 3.77%
Volatility	5.57% 9.42%
ATR (14)	0.27
RSI (14)	30.92
Beta	0.40
Rel Volume	0.02
Avg Volume	3.26M
Volume	49,960

Perf Week	-3.93%
Perf Month	-31.46%
Perf Quarter	-57.85%
Perf Half Y	-88.74%
Perf YTD	-87.98%
Perf Year	-93.02%
Perf 3Y	-93.21%
Perf 5Y	-99.26%
Perf 10Y	-95.33%
Recom	1.00
Target Price	19.00
Prev Close	2.26
Price	2.20
Change %	-2.65%

Aug-24-26 07:50AM	IceCure Signs Exclusive Distribution Agreement for ProSense Cryoablation Systems in the Netherlands (PR Newswire) -6.58%
Aug-20-26 08:10AM	West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation (PR Newswire)
Aug-19-26 11:01PM	Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as US ... (GuruFocus.com)
Aug-13-26 09:10AM	IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation (PR Newswire)
Aug-12-26 01:07PM	IceCure Medical Ltd Q2 2026 Earnings Call Summary (Moby) -11.54%
08:30AM	Loading…
08:30AM	IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year (PR Newswire)
Aug-11-26 09:29AM	Earnings To Watch: Icecure Medical Ltd (ICCM) Q2 2026 -- GF Value Sees 452% Upside (GuruFocus.com) +7.01%
Aug-06-26 08:05AM	IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment (PR Newswire)
Aug-05-26 08:30AM	IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 (PR Newswire)
Jul-29-26 08:25AM	IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense (PR Newswire)
Jul-27-26 08:32AM	IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site (PR Newswire) -6.49%
Jul-14-26 08:32AM	IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense Cryoablation (PR Newswire)
Jul-06-26 08:11AM	IceCure Highlights Expanding Commercial Adoption of ProSense Cryoablation in Brazil Following FDA Clearance for Breast Cancer (PR Newswire) -13.99%
Jun-25-26 08:12AM	IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire) -24.52%
Jun-23-26 08:10AM	IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer (PR Newswire)
01:14PM	Loading…
Jun-17-26 01:14PM	IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor (PR Newswire) +200.47%
12:26PM	ICCM Stock On Track For Best Day In Nearly 5 Years Whats Driving The 200% Rally? (Stocktwits)
08:25AM	IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance (PR Newswire)
Jun-02-26 08:30AM	IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance (PR Newswire) -30.88%
May-20-26 09:00PM	Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-19-26 08:30AM	IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked (PR Newswire)
May-13-26 04:30PM	IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement (PR Newswire)
May-12-26 08:30AM	IceCure Reports First Quarter 2026 Financial Results: ProSense Sales Increase Substantially in the U.S. and North America (PR Newswire)
May-06-26 08:30AM	IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 (PR Newswire) -6.57%
May-05-26 08:30AM	IceCure Showcases ProSense Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market (PR Newswire)
Apr-21-26 08:30AM	IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 (PR Newswire)
Mar-26-26 08:00AM	IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement (PR Newswire) -33.66%
Mar-25-26 08:30AM	IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates (PR Newswire)
Mar-24-26 08:30AM	IceCure Appoints Meir Peleg as Chief Financial Officer (PR Newswire)
Mar-20-26 09:00PM	Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... (GuruFocus.com)
12:40PM	Loading…
Mar-17-26 12:40PM	IceCure Medical Ltd Q4 2025 Earnings Call Summary (Moby) -8.90%
08:30AM	IceCure Reports 2025 Full Year Financial & Operational Results (PR Newswire)
Mar-16-26 09:20AM	What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings (GuruFocus.com) +5.80%
Mar-11-26 08:30AM	U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer (PR Newswire) +8.87%
Mar-10-26 08:30AM	IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 (PR Newswire)
Mar-09-26 08:30AM	American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer (PR Newswire)
Mar-02-26 08:30AM	IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas (PR Newswire) +10.09%
Feb-24-26 08:50AM	IceCure Medical completes 5-year follow up study in kidney cancer cryoablation (TipRanks)
Feb-23-26 08:30AM	IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 (PR Newswire)
Feb-19-26 08:30AM	IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation (PR Newswire)
Feb-11-26 08:30AM	IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense (PR Newswire)
Feb-09-26 04:30PM	IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved (PR Newswire)
Jan-28-26 08:30AM	IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer (PR Newswire)
Jan-12-26 08:30AM	IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense Sales (PR Newswire) -5.46%
Dec-17-25 08:30AM	IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense Cryoablation for Low-Risk Breast Cancer (PR Newswire) +8.68%
Dec-10-25 08:30AM	IceCure's ProSense Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting (PR Newswire)
Dec-05-25 08:30AM	IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes (PR Newswire)
Nov-26-25 08:00PM	Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Nov-19-25 08:54AM	IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 (PR Newswire)
Nov-18-25 08:30AM	IceCure's ProSense Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer (PR Newswire)
07:19AM	Icecure Medical Ltd (ICCM) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-14-25 04:30PM	IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
Nov-12-25 08:30AM	IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 (PR Newswire)
Nov-10-25 08:30AM	IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction (PR Newswire)
Nov-06-25 08:15AM	Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates (Zacks)
Nov-05-25 07:00PM	Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates (Zacks)
Nov-03-25 08:30AM	IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival (PR Newswire)
Oct-13-25 08:30AM	IceCure's ProSense Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances (PR Newswire)
Oct-09-25 08:30AM	IceCure Medical to Attend the 2025 Maxim Growth Summit (PR Newswire)
Oct-06-25 10:16AM	ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment (Zacks)
Oct-03-25 12:28PM	IceCure Medical's ProSense Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care (PR Newswire)
12:19PM	IceCure Receives FDA Marketing Authorization for ProSense Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above (PR Newswire)
Sep-30-25 08:30AM	IceCure's ProSense at the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer, Positive Results from 5 Independent Studies Presented (PR Newswire)
Sep-22-25 08:30AM	IceCure's ProSense Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies Presented (PR Newswire)
Sep-18-25 08:30AM	IceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense Cryoprobes (PR Newswire)
Sep-16-25 12:29PM	Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals (PR Newswire) -5.56%
Sep-15-25 08:30AM	IceCure Receives Regulatory Approval in Israel for its Next-Generation XSense Cryoablation System for Breast Cancer and Other Indications (PR Newswire) +9.59%
Sep-08-25 08:30AM	Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense Cryoablation Achieves Highest Complete Ablation Rate (PR Newswire)
Sep-04-25 08:30AM	IceCure's ProSense Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy (PR Newswire)
Aug-14-25 03:12AM	Icecure Medical Ltd (ICCM) (H1 2025) Earnings Call Highlights: Navigating Challenges and ... (GuruFocus.com)
Aug-13-25 09:40AM	IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates (Zacks)
08:30AM	IceCure Reports Financial & Operational Results for the First Half of 2025 (PR Newswire)
Aug-12-25 09:39AM	Icecure Medical Ltd (ICCM) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-07-25 08:05AM	Viatris (VTRS) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-06-25 08:30AM	IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 (PR Newswire)
Jul-29-25 09:00AM	IceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 Million (PR Newswire)
Jul-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +8.63%
09:00AM	IceCure's ProSense Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation (PR Newswire)
Jul-24-25 09:00AM	IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period (PR Newswire)
08:00AM	Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-10-25 08:00AM	IceCure Announces Commencement of Rights Offering (PR Newswire)
Jul-03-25 08:30AM	IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025 (PR Newswire)
Jun-25-25 09:23AM	IceCure Announces Record Date for Rights Offering for Up to $10 Million (PR Newswire)
Jun-09-25 08:30AM	IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes (PR Newswire)
May-29-25 07:00PM	Icecure Medical Ltd (ICCM) Q1 2025 Earnings Call Highlights: Strategic Advances and Market ... (GuruFocus.com)
May-28-25 08:30AM	IceCure Medical Reports First Quarter 2025 Financial Results (PR Newswire) -8.85%
May-27-25 09:22AM	Icecure Medical Ltd (ICCM) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.60%
May-21-25 08:30AM	IceCure to Report First Quarter 2025 Financial & Operational Results on May 28, 2025 (PR Newswire)
May-12-25 05:05PM	Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.83% +6.87%
May-08-25 05:55PM	Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-06-25 08:30AM	IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense Cryoablation (PR Newswire)
Apr-30-25 08:30AM	IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense Cryoablation in Women 70+ with Early-Stage Breast Cancer (PR Newswire)
Apr-28-25 08:30AM	IceCure Exhibits ProSense & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium (PR Newswire)
Apr-22-25 08:30AM	IceCure's ProSense Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation (PR Newswire)
Mar-28-25 09:16AM	IceCure Medical Stock Dips Despite Positive ICESECRET Study Results (Zacks)
Mar-27-25 01:45PM	IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:30AM	IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense Cryoablation Sales in North America (PR Newswire)
Mar-24-25 08:30AM	IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate (PR Newswire)
Mar-21-25 08:30AM	IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 (PR Newswire)
Mar-20-25 11:02AM	IceCure tumbles after updating plans to seek FDA nod for ProSense (SeekingAlpha) -15.54%

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

CEO & DirectorMr. Eyal Shamir

Chief Operating OfficerMr. Shay Levav

Vice President of Business Development & Global MarketingMs. Tlalit Bussi Tel-Tzure

Vice President of Sales for North AmericaMr. Shad Good

Chief Financial OfficerMr. Meir Peleg

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICCM

Icecure Medical Ltd

Upgrade your Finviz experience